Biotricity (BTCY) Competitors $0.48 +0.00 (+0.46%) As of 01:53 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOptions ChainOwnershipSEC FilingsTrendsBuy This Stock BTCY vs. MODD, OM, BDMD, TELA, DXR, APYX, MDAI, POCI, FEMY, and DRIOShould you be buying Biotricity stock or one of its competitors? The main competitors of Biotricity include Modular Medical (MODD), Outset Medical (OM), Baird Medical Investment (BDMD), TELA Bio (TELA), Daxor (DXR), Apyx Medical (APYX), Spectral AI (MDAI), Precision Optics (POCI), Femasys (FEMY), and DarioHealth (DRIO). These companies are all part of the "medical equipment" industry. Biotricity vs. Modular Medical Outset Medical Baird Medical Investment TELA Bio Daxor Apyx Medical Spectral AI Precision Optics Femasys DarioHealth Biotricity (NASDAQ:BTCY) and Modular Medical (NASDAQ:MODD) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, risk, earnings, profitability, institutional ownership, valuation, media sentiment, analyst recommendations and community ranking. Do insiders & institutionals believe in BTCY or MODD? 3.9% of Biotricity shares are held by institutional investors. Comparatively, 27.5% of Modular Medical shares are held by institutional investors. 10.1% of Biotricity shares are held by company insiders. Comparatively, 20.5% of Modular Medical shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. Is BTCY or MODD more profitable? Modular Medical has a net margin of 0.00% compared to Biotricity's net margin of -80.42%. Biotricity's return on equity of 0.00% beat Modular Medical's return on equity.Company Net Margins Return on Equity Return on Assets Biotricity-80.42% N/A -188.47% Modular Medical N/A -197.97%-162.31% Does the MarketBeat Community believe in BTCY or MODD? Modular Medical received 2 more outperform votes than Biotricity when rated by MarketBeat users. Likewise, 100.00% of users gave Modular Medical an outperform vote while only 0.00% of users gave Biotricity an outperform vote. CompanyUnderperformOutperformBiotricityOutperform VotesNo VotesUnderperform Votes2100.00% Modular MedicalOutperform Votes2100.00% Underperform VotesNo Votes Does the media favor BTCY or MODD? In the previous week, Modular Medical had 3 more articles in the media than Biotricity. MarketBeat recorded 3 mentions for Modular Medical and 0 mentions for Biotricity. Modular Medical's average media sentiment score of 1.16 beat Biotricity's score of 0.00 indicating that Modular Medical is being referred to more favorably in the news media. Company Overall Sentiment Biotricity Neutral Modular Medical Positive Which has better earnings & valuation, BTCY or MODD? Biotricity has higher revenue and earnings than Modular Medical. Modular Medical is trading at a lower price-to-earnings ratio than Biotricity, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBiotricity$12.06M1.01-$14.09M-$1.08-0.45Modular MedicalN/AN/A-$17.47M-$0.53-1.94 Do analysts rate BTCY or MODD? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Biotricity 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00Modular Medical 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Which has more risk & volatility, BTCY or MODD? Biotricity has a beta of 1.33, meaning that its share price is 33% more volatile than the S&P 500. Comparatively, Modular Medical has a beta of 0.33, meaning that its share price is 67% less volatile than the S&P 500. SummaryModular Medical beats Biotricity on 9 of the 15 factors compared between the two stocks. Get Biotricity News Delivered to You Automatically Sign up to receive the latest news and ratings for BTCY and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BTCY vs. The Competition Export to ExcelMetricBiotricitySurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$12.21M$4.33B$5.53B$7.93BDividend YieldN/A39.93%5.11%4.22%P/E Ratio-0.4530.0322.5118.54Price / Sales1.0155.31397.62103.30Price / CashN/A51.0838.1834.62Price / Book-0.386.056.734.25Net Income-$14.09M$68.71M$3.22B$248.18M7 Day Performance6.52%-0.24%1.38%1.03%1 Month Performance53.13%-2.90%2.79%2.70%1 Year Performance-62.37%21.00%15.41%4.05% Biotricity Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BTCYBiotricityN/A$0.48+0.5%N/A-64.2%$12.02M$12.06M-0.4540MODDModular Medical1.9758 of 5 stars$1.02flatN/A-33.5%$41.48MN/A-1.9220Short Interest ↓Negative NewsOMOutset Medical1.0491 of 5 stars$11.44-1.5%$35.00+205.9%-73.9%$41.13M$113.69M-4.61520Upcoming EarningsBDMDBaird Medical InvestmentN/A$6.10+2.5%N/AN/A$40.16M$33.05M0.00N/ATELATELA Bio3.1299 of 5 stars$0.94-2.0%$7.25+671.2%-78.4%$37.19M$69.30M-0.56120Upcoming EarningsShort Interest ↓News CoverageDXRDaxor4.2594 of 5 stars$7.45-0.9%$25.00+235.6%-20.6%$36.04M$2.13M0.0037Gap UpAPYXApyx Medical1.3886 of 5 stars$0.94+4.4%N/A-23.6%$35.53M$48.10M-1.13270Upcoming EarningsShort Interest ↑News CoverageGap DownMDAISpectral AI2.9788 of 5 stars$1.30flat$4.75+265.4%-25.0%$32.91M$29.58M-2.0083Upcoming EarningsShort Interest ↓Positive NewsPOCIPrecision Optics0.6209 of 5 stars$4.29+1.3%N/A-29.2%$32.85M$18.68M-6.7080Positive NewsGap UpHigh Trading VolumeFEMYFemasys3.4399 of 5 stars$1.17+0.9%$11.50+882.9%-10.0%$31.77M$1.63M-1.4430Upcoming EarningsShort Interest ↓Positive NewsDRIODarioHealth2.3902 of 5 stars$0.72-8.5%$1.50+108.4%-50.5%$29.92M$27.04M-0.77200News CoverageGap Up Related Companies and Tools Related Companies Modular Medical Alternatives Outset Medical Alternatives Baird Medical Investment Alternatives TELA Bio Alternatives Daxor Alternatives Apyx Medical Alternatives Spectral AI Alternatives Precision Optics Alternatives Femasys Alternatives DarioHealth Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BTCY) was last updated on 5/2/2025 by MarketBeat.com Staff From Our PartnersTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredTrump Orders 'National Digital Asset Stockpile'Billionaires Rush Into Digital Banking Token Three massive forces are converging right now, creating what c...Crypto 101 Media | SponsoredHere’s How to Claim Your Stake in Elon’s Private Company, xAII predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredMusk's warning signal: Prepare before the cascade beginsWhen Elon Musk triggered his AI layoff plan, most analysts missed what it really meant. Louis Navellier didn’t...InvestorPlace | SponsoredThe next market Nvidia is positioned to dominate …Robots — built by Nvidia. Forbes says this could be " a $24 trillion opportunity for investors." Huang s...Weiss Ratings | SponsoredFeds Just Admitted It—They Can Take Your CashThe Government Just Said Your Money Isn't Yours That's right—According to the DOJ, YOUR hard-earned money i...Priority Gold | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biotricity, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Biotricity With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
